|
| | Publication Year | Title | Author(s) |
| 21 | 20-Jan-2017 | Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory? | Hawkes, Eliza A ; Chong, Geoffrey ; Grigg, Andrew P |
| 22 | 1-May-2015 | Programmed cell death-1 inhibition in lymphoma. | Hawkes, Eliza A ; Grigg, Andrew P ; Chong, Geoffrey |
| 23 | 17-Feb-2015 | Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice. | Hawkes, Eliza A ; Chong, Geoffrey ; Grigg, Andrew P |
| 24 | 30-May-2014 | Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma. | Ciprotti, Marika; Chong, Geoffrey ; Gan, Hui K ; Chan, Anthony; Murone, Carmel ; MacGregor, Duncan; Lee, Fook-Thean; Johns, Terrance G; Heath, Joan K; Ernst, Matthias ; Burgess, Antony W; Scott, Andrew M |
| 25 | 9-Nov-2012 | Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer. | Hannan, Liam M ; Yoong, Jaclyn; Chong, Geoffrey ; McDonald, Christine F |
| 26 | 1-Sep-2010 | Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity. | Chong, Geoffrey ; Tebbutt, Niall C |
| 27 | 19-Mar-2009 | 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma. | Azad, Arun A; Chong, Geoffrey ; Tauro, A; Aly, Ahmad ; Tebbutt, Niall C |
| 28 | 1-Jun-2007 | A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. | Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J |
| 29 | 1-Oct-2001 | Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. | Scott, Andrew M ; Lee, Fook-Thean; Hopkins, Wendie; Cebon, Jonathan S ; Wheatley, J M; Liu, Z; Smyth, Fiona E; Murone, Carmel ; Sturrock, S; MacGregor, Duncan; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, Martin W; Davis, Ian D; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, Geoffrey ; Ritter, G; Hoffman, E W; Burgess, Antony W; Old, Lloyd J |
Loading...
2
0
20
0
false